Search Results 791-800 of 18308 for alopecia

  1. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

    With the exception of alopecia, any unresolved toxicities from prior therapy greater than CTCAE grade 1 at the time of starting study treatment;; Spinal cord ...

  2. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    Patients with Type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin disorders (such as vitiligo, psoriasis, or alopecia) not ...

  3. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    ... alopecia (any grade permissible). No more than one prior chemotherapy regimen for advanced or metastatic breast cancer is allowed; prior chemotherapy for ...

  4. Triamcinolone (topical application route) - Mayo Clinic

    Triamcinolone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid ( ...

  5. Mayo Clinic

    A picture of a former patient, Cassandra Rohrer, motivates Dr. Nyberg to search for regenerative medicine solutions to help patients needing a liver ...

  6. Hypoparathyroidism - Symptoms & causes - Mayo Clinic

    Learn more about this condition in which low levels of parathyroid hormone upset the balance of calcium and phosphorus in the body.

  7. A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) - Mayo Clinic

    treatment-related grade >1 alopecia, treatment related grade 2 peripheral neuropathy, and treatment-related grade 2 hypothyroidism on a stable dose of ...

  8. A Study to Evaluate Niraparib and TSR-042 in Patients with Germline or Somatic BRCA1/2 and PALB2-related Pancreatic Cancer - Mayo Clinic

    ... alopecia prior to initiating protocol therapy. Bisphosphonate therapy and RANKL inhibitors are not considered anti-cancer therapy. Inadequate recovery from ...

  9. Geographic tongue - Symptoms and causes - Mayo Clinic

    Geographic tongue may look alarming, but it does not cause health issues. Sometimes it can cause tongue pain and make you more sensitive to certain foods.

  10. Spina bifida - Symptoms and causes - Mayo Clinic

    Learn about this condition in which an unborn baby's spine and spinal cord don't form properly. Surgery during pregnancy may be a treatment option.